These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20349229)
1. Suppression of C-terminal telopeptide in hypovitaminosis D requires calcium as well as vitamin D. Thomas SD; Need AG; Nordin BE Calcif Tissue Int; 2010 May; 86(5):367-74. PubMed ID: 20349229 [TBL] [Abstract][Full Text] [Related]
2. Analysing the effect of multiple sclerosis on vitamin D related biochemical markers of bone remodelling. McKenna MJ; Murray B; Lonergan R; Segurado R; Tubridy N; Kilbane MT J Steroid Biochem Mol Biol; 2018 Mar; 177():91-95. PubMed ID: 28887146 [TBL] [Abstract][Full Text] [Related]
3. High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese women. Kruger MC; Ha PC; Todd JM; Kuhn-Sherlock B; Schollum LM; Ma J; Qin G; Lau E Eur J Clin Nutr; 2012 Jul; 66(7):856-61. PubMed ID: 22644348 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Björkman M; Sorva A; Risteli J; Tilvis R Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037 [TBL] [Abstract][Full Text] [Related]
5. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772 [TBL] [Abstract][Full Text] [Related]
6. Calcium and vitamin d supplementation in postmenopausal women. Aloia JF; Dhaliwal R; Shieh A; Mikhail M; Islam S; Yeh JK J Clin Endocrinol Metab; 2013 Nov; 98(11):E1702-9. PubMed ID: 24064695 [TBL] [Abstract][Full Text] [Related]
7. Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women. Bonjour JP; Benoit V; Payen F; Kraenzlin M J Clin Endocrinol Metab; 2013 Jul; 98(7):2915-21. PubMed ID: 23653431 [TBL] [Abstract][Full Text] [Related]
9. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people. Sayed-Hassan R; Abazid N; Alourfi Z Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Bhattoa HP; Bettembuk P; Ganacharya S; Balogh A Osteoporos Int; 2004 Jun; 15(6):447-51. PubMed ID: 15205715 [TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D supplementation on bone turnover markers and other bone-related substances in subjects with vitamin D deficiency. Jorde R; Stunes AK; Kubiak J; Joakimsen R; Grimnes G; Thorsby PM; Syversen U Bone; 2019 Jul; 124():7-13. PubMed ID: 30959189 [TBL] [Abstract][Full Text] [Related]
12. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study. Wamberg L; Pedersen SB; Richelsen B; Rejnmark L Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713 [TBL] [Abstract][Full Text] [Related]
13. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Valderas JP; Velasco S; Solari S; Liberona Y; Viviani P; Maiz A; Escalona A; González G Obes Surg; 2009 Aug; 19(8):1132-8. PubMed ID: 19517199 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients. Peacey SR; Wright D; Harries MJ Clin Endocrinol (Oxf); 2004 Nov; 61(5):603-6. PubMed ID: 15521963 [TBL] [Abstract][Full Text] [Related]
16. Sickle cell bone disease: response to vitamin D and calcium. Adewoye AH; Chen TC; Ma Q; McMahon L; Mathieu J; Malabanan A; Steinberg MH; Holick MF Am J Hematol; 2008 Apr; 83(4):271-4. PubMed ID: 17924548 [TBL] [Abstract][Full Text] [Related]
17. Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women. Ling Y; Wang Z; Wu B; Gao X J Bone Miner Metab; 2018 May; 36(3):352-363. PubMed ID: 28642975 [TBL] [Abstract][Full Text] [Related]
18. Response of a single 'mega intramuscular dose' of vitamin D on serum 25OHD and parathyroid hormone levels. Khan AH; Rohra DK; Saghir SA; Udani SK; Wood R; Jabbar A J Coll Physicians Surg Pak; 2012 Apr; 22(4):207-12. PubMed ID: 22482374 [TBL] [Abstract][Full Text] [Related]
19. The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function. Pekkarinen T; Välimäki VV; Aarum S; Turpeinen U; Hämäläinen E; Löyttyniemi E; Välimäki MJ Clin Endocrinol (Oxf); 2010 Apr; 72(4):455-61. PubMed ID: 19486025 [TBL] [Abstract][Full Text] [Related]
20. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]